Regulation of Transcriptional Activation of mdm2 Gene by p53 in Response to UV Radiation

Cell Growth and Differentiation

Volumn 9, Issue 2, 1998, Pages 119-130

  Saucedo, Leslie J ^a   Carstens, Brian P ^a,b   Seavey, Scott E ^a   Albee II, Lee D ^a,c   Perry, Mary Ellen ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MDM2 PROTEIN, MOUSE; MDM2 PROTEIN, RAT; MESSENGER RNA; MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL LINE; CELL NUCLEUS; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; PROMOTER REGION; RADIATION RESPONSE; RAT; SERODIAGNOSIS; TRANSACTIVATION; ULTRAVIOLET RADIATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; CELL LINE, TRANSFORMED; CELL NUCLEUS; DNA; DOSE-RESPONSE RELATIONSHIP, RADIATION; MICE; NUCLEAR PROTEINS; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RATS; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0031992607     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, Jr., C. A., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
2. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
3. Cho, Y., Gorina, S., Jeffrey, P. D., and Pavletich, N. P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science (Washington DC), 265: 346-355, 1994.
4. Pietenpol, J. A., Tokino, T., Thiagalingam, S., El-Deiry, W. S., Kinzler, K. W., and Vogelstein, B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA, 97: 1998-2002, 1994.
5. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
6. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and gadd45 is defective in ataxia telangiectasia. Cell, 71: 587-597, 1992.
7. Wu, X., Bayle, J. H., Olson, D., and Levine, A. J. The p53-mdm2 autoregulatory feedback loop. Genes Dev., 7: 1126-1132, 1993.
8. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995.
9. Gottlieb, T. M., and Oren, M. p53 in growth control and neoplasia. Biochim. Biophys. Acta, 1287: 77-102, 1996.
10. Lin, J., Chen, J., Elenbaas, B., and Levine, A. J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm2 and the adenovirus 5 E1B 55-kD protein. Genes Dev., 8: 1235-1246, 1994.
11. Thut, C. J., Chen, J-L., Klemm, R., and Tjian, R. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science (Washington DC), 267: 100-104, 1995.
12. Gu, W., Shi, X-L., and Roeder, R. Synergistic activation of transcription by CBP and p53. Nature (Lond.), 387: 819-822, 1997.
13. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., and Vogelstein, B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (Lond.), 353: 80-83, 1992.
14. Bueso-Ramos, C. E., Yang, Y., deLeon, E., McCown, P., Stass, S. A., and Albitar, M. The human MDM-2 oncogene is overexpressed in leukemias. Blood, 82: 2617-2623, 1993.
15. Marchetti, A., Buttitta, F., Girlando, S., Dalla Palma, P., Pellegrini, S., Fina, P., Doglioni, C., Bevilacqua, G., and Barbareschi, M. Mdm2 gene alterations and MDM2 protein expression in breast carcinomas. J. Pathol., 175:31-38, 1995.
16. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69: 1237-1245, 1992.
17. Chen, J., Marechal, V., and Levine, A. J. Mapping of the p53 and MDM2 interaction domains. Mol. Cell. Biol., 13: 4107-4114, 1993.
18. Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., and Vogelstein, B. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature (Lond.), 362: 857-860, 1993.
19. Moll, U. M., Riou, G., and Levine, A. J. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA, 890: 7262-7266, 1992.
20. Moll, U. M., LaQuaglia, M., Benard, J., and Riou, G. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA, 92: 4407-4411, 1995.
21. Lutzker, S., and Levine, A. J. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat. Med., 2: 804-810, 1996.
22. Weinberg, W. C., Azzoli, C. G., Chapman, K., Levine, A. J., and Yuspa, S. H. p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein. Oncogene, 10: 2271-2279, 1995.
23. Perry, M. E., Piette, J., Zawadski, J. A., Harvey, D., and Levine, A. J. The mdm2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. USA, 90: 11623-11627, 1993.
24. Lu, X., Burbidge, S. A., Griffin, S., and Smith, H. Discordance between accumulated p53 protein level and its transcriptional activity in response to u.v. radiation. Oncogene, 13: 413-418, 1996.
25. Maltzman, W., and Czyzyk, L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol., 4: 1689-1694, 1984.
26. Zhan Q., Carrier, F., and Fornace, A. J. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol., 13: 4242-4250, 1993.
27. 1 arrest in UV-irradiated human skin fibroblasts. Cancer Res., 57: 3390-3394, 1997.
28. Hupp, T. R., Sparks, A., and Lane, D. P. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell, 83: 237-245, 1995.
29. Jayaraman, L., and Prives, C. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell, 81: 1021-1029, 1995.
30. Barak, Y., Gottlieb, E., Juven-Gershon, T., and Oren, M. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes Dev., 8: 1739-1749, 1994.
31. Price, B. D., and Park, S. J. DNA damage increases the level of mdm2 messenger RNA in wtp53 human cells. Cancer Res., 54: 896-899, 1994.
32. Mayo, L. D., and Berberich, S. J. Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation. Oncogene, 13: 2315-2321, 1996.
33. Juven, T., Barak, Y., Zauberman, A., George, D. L., and Oren, M. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene, 8: 3411-3416, 1993.
34. Fakharzadeh, S., Trusko, S. P., and George, D. L. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J., 10: 1565-1569, 1991.
35. Jones, S. N., Ansari-Lari, M. A., Hancock, A. R., Jones, W. J., Gibbs, R. A., Donehower, L. A., and Bradley, A. Genomic organization of the mouse double minute 2 gene. Gene (Amst.), 175: 209-213, 1996.
36. Mayne, L. V., and Lehman, A. R. Failure of RNA synthesis to recover after UV irradiation: an early detect in cells from individuals with Cockayne's syndrome and xeroderma pigmentosum. Cancer Res., 42: 1473-1478, 1982.
37. Bender, K., Blattner, C., Knebel, A., lordanov, M., Herrlich, P., and Rahmsdorf, H. J. UV-induced signal transduction. J. Photochem. Photobiol. B Biol., 37: 1-17, 1997.
38. Devary, Y., Gottlieb, R. A., Lau, L. F., and Karin, M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol., 11: 2804-2811, 1991.
39. Okamoto, K., and Beach, D. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J., 13: 4816-4822, 1994.
40. Hupp, T. R., and Lane, D. P. Allosteric activation of latent p53 tetramers. Curr. Biol., 4: 865-875, 1994.
41. Hupp, T. R., and Lane, D. P. Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner. J. Biol. Chem., 270: 18165-18174, 1995.
42. Halozonetis, T. D., and Kandil, A. N. Gonformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J., 12: 5057-5064, 1993.
43. Halozonetis, T. D., Davis, L. J., and Kandil, A. N. Wild-type p53 adopts a "mutant" like conformation when bound to DNA. EMBO J., 12: 1021-1028, 1993.
44. McKay, R. D. G. Binding of simian virus 40 T antigen-related protein to DNA. J. MoL. Biol., 145: 471-488, 1981.
45. Lane, D. P., Stephen, C. W., Midgley, C. A., Sparks, A., Hupp, T. R., Daniels, D. A., Greaves, R., Reid, A., Vojtesek, B., and Picksley, S. M. Epitope analysis of the murine p53 tumour suppressor protein. Oncogene, 12: 2461-2466, 1996.
46. Takenaka, I., Morin, F., Seizinger, B. R., and Kley, N. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem., 270: 5405-5411, 1995.
47. Price, B. D., and Calderwood, S. K. Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene, 8: 3055-3063, 1993.
48. Hackett, P. B., and Sauerbier, W. The transcriptional organization of the ribosomal RNA genes in mouse L cells. J. Mol. Biol., 97: 235-256, 1975.
49. Deffie, A., Hao, M., Montes de Oca Luna, R., Hulboy, D. L., and Lozano, G. Cyclin E restores p53 activity in contact-inhibited cells. Mol. Cell. Biol., 15: 3926-3933, 1995.
50. Jayaraman, L., Murthy, K. G. K., Zhu, C., Curran, T., Xanthiudakis, S., and Prives, C. Identification of a redox/repair protein Ref-1 as a potent activator of p53. Genes Dev., 11: 558-570, 1997.
51. Avantaggiati, M. L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A. S., and Kelly, K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell, 89: 1175-1184, 1997.
52. Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., and Livingston, D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature (Lond.), 387: 823-827, 1997.
53. Wu, L., and Levine, A. J. Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation: p53-dependent and p53-independent regulation of the mdm2 gene. Mol. Med., 3: 441-451, 1997.
54. Wang, X. W., Yeh, H., Schaeffer, L. Roy, R., Moncollin, V., Egly, J-M., Wang, Z., Friedberg, E. C., Evans, M. K., Taffe, B. G., Bohr, V. A., Weeda, G., Hoeijmakers, J. H. J., Forrester, K., and Harris, C. C. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet., 10: 188-195, 1995.
55. Svejstrup, J. Q., Wang, Z., Feaver, W. J., Wu, X., Bushnell, D. A., Donahue, T. F., Friedberg, E. C., and Kornberg, R. D. Different forms of TFIIH for transcription and DNA repair: holo-TFIIH and a nucleotide excision repairosome. Cell, 80: 21-28, 1995.
56. Adamczewski, J. P., Rossignol, M., Tassan, J-P., Nigg, E. A., Moncollin, V., and Egly, J-M. MAT1, cdk7 and cyclin H form a kinase complex which is UV light-sensitive upon association with TFIIH. EMBO J., 15: 1877-1884, 1996.
57. Akoulitchev, A., Makela, T. P., Weinberg, R. A., and Reinberg, D. Requirement for TFIIH kinase activity I transcription by RNA polymerase II. Nature (Lond.), 377: 557-560, 1995.
58. Svejstrup, J. Q., Vichi, P., and Egly, J-M. The multiple role of transcription/repair factor TFIIH. Trends Biochem., 21: 346-350, 1996.
59. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. MDM2 promotes rapid degradation of p53. Nature (Lond.), 387: 296-299, 1997.
60. Kubbutat, M. H. G., Jones, S. N., and Vousden, K. H. Regulation of p53 stability by MDM2. Nature (Lond.), 387: 299-303, 1997.
61. Zeigler, A., Jonason, A. S., Lefell, D. J., Simon, J. A., Sharma, H. W., Kimmelman, J., Remington, L., Jacks, T., and Brash, D. E. Sunburn and p53 in the onset of skin cancer. Nature (Lond.), 372: 773-776, 1994.
62. Haupt, Y., Barak, Y., and Oren, M. Cell type-specific inhibition of p53-mediated apoptosis by MDM2. EMBO J., 15: 1596-1606, 1996.
63. Sherley, J. Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration. J. Biol. Chem., 266: 24815-24828, 1991.
64. Harvey, D., and Levine, A. J. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev., 5: 2375-2385, 1991.
65. Finlay, C. A., Hinds, P. W., Tan, T-H., Eliyahu, D., Oren, M., and Levine, A. J. Activating mutations for transformation by p53 produce a gene product that forms an hsc70 - p53 complex with an altered half-life. Mol. Cell. Biol., 8: 531-539, 1988.
66. Hinds, P. W., Finlay, C. A., Frey, A. B., and Levine, A. J. Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines. Mol. Cell. Biol., 7: 2863-2869, 1987.
67. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
68. Harlow, E., Crawford, L. V., Pim, D. C., and Williamson, N. M. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol., 39: 861-869, 1981.
69. Olson, D. C., Marechal, V., Momand, J., Chen, J., Romocki, C., and Levine, A. J. Identification and characterization of multiple MDM2 proteins and MDM2-p53 complexes. Oncogene, 8: 2353-2360, 1993.
70. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
71. Treizenberg, S. J. Primer extension. In: F. M. Ausbel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (eds.), Current Protocols in Molecular Biology, pp. 4.8.1-4.8.5, New York: John Wiley & Sons, Inc., 1992.
72. El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., and Vogelstein, B. Definition of a consensus binding site for p53. Nat. Genet., 1: 45-49, 1992.
73. Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Freidman, P., Prives, C., and Vogelstein, B. Identification of p53 as a sequence-specific DNA-binding protein. Science (Washington DC), 252: 1708-1711, 1991.